Zolbetuximab
id:
zolbetuximab-185-3013133
title:
Zolbetuximab
text:
Zolbetuximab, sold under the brand name Vyloy, is a monoclonal antibody against isoform 2 of Claudin-18 used for the treatment of gastric cancer. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. Zolbetuximab was developed by Ganymed Pharmaceuticals AG. Astellas Pharmaceuticals acquired the rights to zolbetuximab in December 2016, when it acquired Ganymed Pharmaceuticals.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Zolbetuximab
date created:
2013-12-20T21:50:51Z
date modified:
2024-09-07T15:22:00Z
main entity:
{"identifier":"Q17107865","url":"https://www.wikidata.org/entity/Q17107865"}
image:
fields total:
13
integrity:
15